Title : Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.

Pub. Date : 2002 Jul

PMID : 12086935






8 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
2 We recently reported that AMPK is activated by metformin in cultured rat hepatocytes, mediating the inhibitory effects of the drug on hepatic glucose production. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
3 In the present study, we evaluated whether therapeutic doses of metformin increase AMPK activity in vivo in subjects with type 2 diabetes. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
4 Metformin treatment for 10 weeks significantly increased AMPK alpha2 activity in the skeletal muscle, and this was associated with increased phosphorylation of AMPK on Thr172 and decreased acetyl-CoA carboxylase-2 activity. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
5 Metformin treatment for 10 weeks significantly increased AMPK alpha2 activity in the skeletal muscle, and this was associated with increased phosphorylation of AMPK on Thr172 and decreased acetyl-CoA carboxylase-2 activity. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
6 The increase in AMPK alpha2 activity was likely due to a change in muscle energy status because ATP and phosphocreatine concentrations were lower after metformin treatment. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
7 Metformin-induced increases in AMPK activity were associated with higher rates of glucose disposal and muscle glycogen concentrations. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
8 These findings suggest that the metabolic effects of metformin in subjects with type 2 diabetes may be mediated by the activation of AMPK alpha2. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus